 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
 |
 |
 |
Phase: |
 |
Phase 3 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1750 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
70: Cares for self, unable to perform normal activity or to do active work |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Not Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
09/22/2012 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
Newly diagnosed only. |
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Surgery Chemotherapy Radiation Immunological, Biological or Targeted Therapy |
 |
 |
 |
 |
Contact: |
 |
Karen Fink MD, PHD Baylor University Medical Center at Dallas Neuro-Oncology Associates / Contact: Joseph Moler, RN, MSN 3600 Gaston Ave. Barnett Tower Suite 605 Dallas, TX 75246 USA Phone: 214-820-8685 Fax: 214-820-8691 E-mail: Joseph.Moler@baylorhealth.edu Website: www.neuro-oncologyassociates.com |
 |
 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is a combination of our internal ID and the official ID for the trial, if any.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
|
|